Search Results

Filter
  • 1-10 of  458,389 results for ""NEUROBLASTOMA""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Osteopathia striata with cranial sclerosis as a cancer predisposition syndrome: The first report of neuroblastoma and review of all cancers in OSCS.

  • Authors : Abu-El-Haija A; Division of Medical Genetics and Genomics, Department of Pediatrics, Boston Children's Hospital, Boston, USA.; Harvard Medical School, Boston, USA.

Subjects: Osteosclerosis*/Osteosclerosis*/Osteosclerosis*/genetics ; Osteosclerosis*/Osteosclerosis*/Osteosclerosis*/pathology ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/genetics Osteopathia striata cranial sclerosis

  • Source: American journal of medical genetics. Part A [Am J Med Genet A] 2024 Oct; Vol. 194 (10), pp. e63709. Date of Electronic Publication: 2024 May 27.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101235741 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

L3MBTL2 maintains MYCN-amplified neuroblastoma cell proliferation through silencing NRIP3 and BRME1 genes.

  • Authors : Okada R; Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan.; Laboratory of Tumor Molecular Biology, Department of Graduate School of Science and Engineering, Saitama University, Saitama, Japan.

Subjects: Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/genetics ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/metabolism ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/pathology

  • Source: Genes to cells : devoted to molecular & cellular mechanisms [Genes Cells] 2024 Oct; Vol. 29 (10), pp. 838-853. Date of Electronic Publication: 2024 Aug 27.Publisher: Blackwell Science Ltd Country of Publication: England NLM ID: 9607379 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Tracking changes in image-defined risk factors during neoadjuvant chemotherapy and their predictive value for surgical outcomes based on the International Neuroblastoma Surgical Report Form.

  • Authors : Liu T; Department of General Surgery, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Sheng Q

Subjects: Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/surgery ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/drug therapy ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/pathology

  • Source: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Oct; Vol. 71 (10), pp. e31161. Date of Electronic Publication: 2024 Jul 10.Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Predictive value of 18 F-FDG PET/CT versus bone marrow biopsy and aspiration in pediatric neuroblastoma.

  • Authors : Zhao Z; Department of Surgical oncology, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, 400014, China.; Yang C

Subjects: Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/diagnostic imaging ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/pathology ; Fluorodeoxyglucose F18*

  • Source: Clinical & experimental metastasis [Clin Exp Metastasis] 2024 Oct; Vol. 41 (5), pp. 627-638. Date of Electronic Publication: 2024 Apr 13.Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 8409970 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Targeted inhibition of glycogen synthase kinase-3 using 9-ING-41 (elraglusib) enhances CD8 T-cell-reactivity against neuroblastoma cells.

  • Authors : Markovska A; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3508 GA, Utrecht, The Netherlands.; Somers K

Subjects: Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/immunology ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/pathology ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/genetics

  • Source: Scientific reports [Sci Rep] 2024 Sep 17; Vol. 14 (1), pp. 21710. Date of Electronic Publication: 2024 Sep 17.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Establishment and characterization of a novel MDM2/MYCN-co-amplified neuroblastoma cell line, NBN-SHIM, established from a late recurrent stage MS tumor.

  • Authors : Kato K; Divisions of Pathology, Kanagawa Children's Medical Center, Yokohama, Japan. .; Division of Pediatric Hematology and Oncology, Institute of Pediatric Medicine and Cancer Research, Ibaraki Children's Hospital, Futaba-dai 3-3-1, Mito, Ibaraki, Japan. .

Subjects: Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/genetics ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/pathology ; Proto-Oncogene Proteins c-mdm2*/Proto-Oncogene Proteins c-mdm2*/Proto-Oncogene Proteins c-mdm2*/genetics

  • Source: Human cell [Hum Cell] 2024 Sep; Vol. 37 (5), pp. 1602-1609. Date of Electronic Publication: 2024 Jul 30.Publisher: Springer Country of Publication: Japan NLM ID: 8912329 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1749-0774

Record details

×
Academic Journal

KLF7 promotes neuroblastoma differentiation through the GTPase signaling pathway by upregulating neuroblast differentiation-associated protein AHNAKs and glycerophosphodiesterase GDPD5.

  • Authors : Qiao S; Heilongjiang Province Key Laboratory of Child Development and Genetic Research, Harbin Medical University, China.; Department of Child and Adolescent Health, Public Health College, Harbin Medical University, China.

Subjects: Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/pathology ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/genetics ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/metabolism

  • Source: The FEBS journal [FEBS J] 2024 Sep; Vol. 291 (17), pp. 3870-3888. Date of Electronic Publication: 2024 Jun 26.Publisher: Published by Blackwell Pub. on behalf of the Federation of European Biochemical Societies Country of Publication: England NLM ID: 101229646 Publication

Record details

×
Academic Journal

Atypical hemolytic uremic syndrome during induction chemotherapy in neuroblastoma, a rare phenomenon or common congenital predisposition?

  • Authors : Davitt M; Lisa Dean Mosely Foundation Institute for Cancer and Blood Disorders, Nemours Children's Hospital, Wilmington, Delaware, USA.; Offenbacher R

Subjects: Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/drug therapy ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/pathology ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/genetics

  • Source: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Sep; Vol. 71 (9), pp. e31175. Date of Electronic Publication: 2024 Jul 03.Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Molecular profiling of core immune-escape genes highlights TNFAIP3 as an immune-related prognostic biomarker in neuroblastoma.

  • Authors : Yang L; Department of Pediatric Surgical Oncology Children's Hospitial of Chongqinng Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Children's Hospital of Chongqing Medical University, Chongqing, China.; Huang K

Subjects: Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/genetics ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/immunology ; Tumor Necrosis Factor alpha-Induced Protein 3*/Tumor Necrosis Factor alpha-Induced Protein 3*/Tumor Necrosis Factor alpha-Induced Protein 3*/genetics

  • Source: Inflammation research : official journal of the European Histamine Research Society ... [et al.] [Inflamm Res] 2024 Sep; Vol. 73 (9), pp. 1529-1545. Date of Electronic Publication: Publisher: Birkhäuser Country of Publication: Switzerland NLM ID: 9508160 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Higher tumor mutational burden is associated with inferior outcomes among pediatric patients with neuroblastoma.

  • Authors : Chang YH; Institute of Molecular and Genomic Medicine, National Health Research Institute, Miaoli, Taiwan.; Yu CH

Subjects: Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/genetics ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/mortality ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/pathology

  • Source: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Sep; Vol. 71 (9), pp. e31176. Date of Electronic Publication: 2024 Jul 05.Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  458,389 results for ""NEUROBLASTOMA""